Abbott Vascular says it will approach FDA to design a U.S. clinical trial for its bioabsorbable everolimus-eluting stent once it gets data from a few hundred more patients in its overseas trials
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Synchron is preparing a pilot study of its fully wireless, second-gen brain-computer interface after an ALS patient controlled an iPad solely by thought. If all goes as planned, Synchron’s BCI will move into pivotal trials in 2026.
Apreo Health CEO Karun Naga talks to Medtech Insight about the company’s intentions for its Series B funding. The Breathe-3 clinical trial and early commercialization activities, involving physician education, are top priorities.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
